Skip to content

A verification study on effects of antioxidant and skin improvement in healthy Japanese adults: a open-label trial

A verification study on effects of antioxidant and skin improvement in healthy Japanese adults: a open-label trial - A verification study on effects of antioxidant and skin improvement in healthy Japanese adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022761
Enrollment
26
Registered
2016-06-15
Start date
2016-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 8 weeks Test material: Paste of Fermented Plant Extract AO Dose: 1 pack a day Administration: Take the test food before breakfast

Sponsors

ORTHOMEDICO, Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult females 2. Healthy adult females who feel fatigue

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, Irritable Bowel Syndrome (IBS) or other chronic diseases 3. Currently taking medicines (include herbal medicines), supplements, Food for Specified Health Uses, and/or Foods with Functional Claims 4. Allergic to soybean, apple, banana, peach, kiwi fruit, yam, sesame, medicines or foods related to the test food of this trial 5. Pregnant, lactating, or planning to get pregnant during the trial period 6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 7. Judged unsuitable for participating in this trial by physician

Design outcomes

Primary

MeasureTime frame
1. Urine 8-hydroxydeoxyguanosine 2. Blood potential anti oxidant 3. Simplified Oxidative Stress Profile 4. Hexanoyl lysine (HEL) 5. Propanoyl lysine (PRL) *Measuring points: at 0 week and 8 weeks after ingestion

Secondary

MeasureTime frame
1. Questionnaire (Likert scale) 2. Skin oiliness 3. Skin moisture 4. Skin elasticity 5. Magnified image skin diagnosis *Measuring points: at 0 week and 8 weeks after ingestion

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026